Connect with us

Product Watch

Agappe launches Mispa CountX

Mispa CountX, an indigenously-built 3-part hematology analyzer, has been recently launched in partnership with L&T Technology Services. The innovation from the Agappe-LTTS alliance promises to revolutionize the diagnostics landscape in India particularly on the backdrop of the affordability aspect that it enables.
With its Hematology Project, the company aims to reach the masses with this instrument, which is placed across India penetrating the unreached territories. The purpose is to bring down the cost per test to make healthcare affordable, so that it can be considered as a basic right of an individual without compromising on the quality and the comparability of the test.

MALDI-TOF a revolution in clinical microbial identification

Thomas John
Managing Director,
Agappe Diagnostics ltd.

“Agappe aims at providing global standard of care at Indian prices, affordable, and accessible to the rural Indian population. We take pride in our innovations as we bring forth and always push to introduce the most updated technologies to be mass produced at a competent price. Our aim is to change the way we perceive healthcare from the reactive approach to a more pro-active approach for diagnosis. To help us achieve this status, we got the able support from L&T, their extensive technological expertise to develop similar instruments that is tailor-made for the Indian subcontinent. The influence and grasp of the institution that was instrumental in molding the modern India is bound to make Mispa CountX, one of the flagship models in the Indian hematology market.”

Copyright © 2024 Medical Buyer

error: Content is protected !!